These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 9741048)

  • 21. Repression of the human immunodeficiency virus type-1 long terminal repeat by the c-Myc oncoprotein.
    Stojanova A; Caro C; Jarjour RJ; Oster SK; Penn LZ; Germinario RJ
    J Cell Biochem; 2004 May; 92(2):400-13. PubMed ID: 15108364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid-associated membrane proteins of Mycoplasma fermentans and M. penetrans activate human immunodeficiency virus long-terminal repeats through Toll-like receptors.
    Shimizu T; Kida Y; Kuwano K
    Immunology; 2004 Sep; 113(1):121-9. PubMed ID: 15312143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential regulation of human immunodeficiency virus type 2 and simian immunodeficiency virus promoter activity.
    Hiebenthal-Millow K; Pöhlmann S; Münch J; Kirchhoff F
    Virology; 2004 Jul; 324(2):501-9. PubMed ID: 15207635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reactive oxygen species activate HIV long terminal repeat via post-translational control of NF-kappaB.
    Pyo CW; Yang YL; Yoo NK; Choi SY
    Biochem Biophys Res Commun; 2008 Nov; 376(1):180-5. PubMed ID: 18765232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secretion of extracellular factor(s) induced by X-irradiation activates the HIV type 1 long terminal repeat through its kappaB motif.
    Faure E; Rameil P; Lecine P; Rey F; Sire J; Kahn-Perles B; Imbert J
    AIDS Res Hum Retroviruses; 1998 Mar; 14(4):353-65. PubMed ID: 9519897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vasoactive intestinal peptide 1-12: a ligand for the CD4 (T4)/human immunodeficiency virus receptor.
    Sacerdote P; Ruff MR; Pert CB
    J Neurosci Res; 1987; 18(1):102-7. PubMed ID: 3682024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attachment of human immunodeficiency virus-1 (HIV-1) particles bearing host-encoded B7-2 proteins leads to nuclear factor-kappa B- and nuclear factor of activated T cells-dependent activation of HIV-1 long terminal repeat transcription.
    Bounou S; Dumais N; Tremblay MJ
    J Biol Chem; 2001 Mar; 276(9):6359-69. PubMed ID: 11096063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell-to-cell contact activates the long terminal repeat of human immunodeficiency virus 1 through its kappaB motif.
    Faure E; Lecine P; Lipcey C; Champion S; Imbert J
    Eur J Biochem; 1997 Mar; 244(2):568-74. PubMed ID: 9119025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early replication steps but not cell type-specific signalling of the viral long terminal repeat determine HIV-1 monocytotropism.
    Schuitemaker H; Groenink M; Meyaard L; Kootstra NA; Fouchier RA; Gruters RA; Huisman HG; Tersmette M; Miedema F
    AIDS Res Hum Retroviruses; 1993 Jul; 9(7):669-75. PubMed ID: 8369171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective inhibition of mitogen-induced transactivation of the HIV long terminal repeat by carboxyamidotriazole. Calcium influx blockade represses HIV-1 transcriptional activation.
    Yasui H; Butscher W; Cohen M; Spriggs N; Wersto R; Kohn EC; Liotta L; Gardner K
    J Biol Chem; 1997 Nov; 272(45):28762-70. PubMed ID: 9353347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional similarities between human immunodeficiency virus type 1 and simian virus 40 kappa B proto-enhancers.
    Phares W; Herr W
    J Virol; 1991 May; 65(5):2200-10. PubMed ID: 1850006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a novel cell-type and context specific enhancer within the negative regulatory element of the human immunodeficiency virus type 1 long terminal repeat.
    Sikder SK; Mitra D; Laurence J
    Arch Virol; 1994; 137(1-2):139-47. PubMed ID: 7979987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of long terminal repeat U3 sequences overlapping the transcription control region in human immunodeficiency virus type 1 mRNA 3' end formation.
    DeZazzo JD; Kilpatrick JE; Imperiale MJ
    Mol Cell Biol; 1991 Mar; 11(3):1624-30. PubMed ID: 1996111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rescue of thymocytes from cell death by vasoactive intestinal peptide.
    Ernström U; Gafvelin G; Mutt V
    Regul Pept; 1995 May; 57(2):99-104. PubMed ID: 7659793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation-dependent human immunodeficiency virus long terminal repeat regulatory elements active in human teratocarcinoma cells.
    Zeichner SL; Hirka G; Andrews PW; Alwine JC
    J Virol; 1992 Apr; 66(4):2268-73. PubMed ID: 1548760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crystal structure of NFAT bound to the HIV-1 LTR tandem kappaB enhancer element.
    Bates DL; Barthel KK; Wu Y; Kalhor R; Stroud JC; Giffin MJ; Chen L
    Structure; 2008 May; 16(5):684-94. PubMed ID: 18462673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel cis-acting element that controls transcription of human immunodeficiency virus type 1 DNA, depending on cell type.
    Nakanishi Y; Masamune Y; Kobayashi N
    J Virol; 1991 Nov; 65(11):6334-8. PubMed ID: 1920636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo depression of lymphocyte traffic in sheep by VIP and HIV (AIDS)-related peptides.
    Moore TC; Spruck CH; Said SI
    Immunopharmacology; 1988; 16(3):181-9. PubMed ID: 3267011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NF-kappa B and HIV: linking viral and immune activation.
    Rabson AB; Lin HC
    Adv Pharmacol; 2000; 48():161-207. PubMed ID: 10987091
    [No Abstract]   [Full Text] [Related]  

  • 40. [Anti-HIV chemotherapy targeted at host-cellular factors].
    Baba M
    Uirusu; 1996 Dec; 46(2):155-60. PubMed ID: 9123887
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.